References
- Gilks, W.R.; Bradley, B.A.; Gore, S.M.; Klouda, P.T. Substantial benefits of tissue matching in renal transplantation. Transplantation. 1987; 43 (5):669–674.
- Bradley, B.A. The role of HLA matching in transplantation. Immunol. Lett. 1991; 29 (1–2):55–59.
- Terasaki, P.I.; Ozawa, M. Predicting kidney graft failure by HLA antibodies: a prospective trial. Am. J. Transplant. 2004; 4 (3):438–443.
- Terasaki, P.I.; Ozawa, M. Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a 2-year prospective trial. Transplantation. 2005; 80 (9):1194–1197.
- Prin Mathieu, C.; Renoult, E.; Kennel De March, A.; Béné, M.C.; Kessler, M.; Faure, G.C. Serum anti-rabbit and anti-horse IgG, IgA, and IgM in kidney transplant recipients. Nephrol. Dial. Transplant. 1997; 12 (10):2133–2139.
- Pescovitz, M.D.; Book, B.K.; Henson, S.; Leapman, S.B.; Milgrom, M.L.; Kimball, J.; Norman, D.; Filo, R.S. The addition of sirolimus to cyclosporine and steroids inhibits the anti-equine antibody response in renal transplant recipients treated with antithymocyte globulin. Am. J. Transplant. 2003; 3 (4):497–500.
- Grailer, A.; Nichols, J.; Hullett, D.; Sollinger, H.W.; Burlingham, W.J. Inhibition of human B cell responses in vitro by RS-61443, cyclosporine A and DAB486 IL-2. Transplant. Proc. 1991; 23 (1 Pt 1):314–315.
- Feucht, H.E.; Mihatsch, M.J. Diagnostic value of C4d in renal biopsies. Curr. Opin. Nephrol. Hypertens. 2005; 14 (6):592–598.
- Kowalski, R.; Post, D.; Schneider, M.C.; Britz, J.; Thomas, J.; Deierhoi, M.; Lobashevsky, A.; Redfield, R.; Schweitzer, E.; Heredia, A.; Reardon, E.; Davis, C.; Bentlejewski, C.; Fung, J.; Shapiro, R.; Zeevi, A. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin. Transplant. 2003; 17 (2):77–88.